| Literature DB >> 34063602 |
Ying-Cheng Chen1,2, Cheng-Hsun Chuang1,3,4, Ming-Hong Hsieh3,5, Han-Wei Yeh6, Shun-Fa Yang1,7, Chiao-Wen Lin8, Ying-Tung Yeh9,10, Jing-Yang Huang1,7, Pei-Lun Liao7, Chi-Ho Chan7,11, Chao-Bin Yeh1,3,4.
Abstract
Patients with pelvic fractures could encounter various complications during or after treatments. This cohort study investigated the risk of mortality and readmissions in patients with pelvic fractures, with or without urinary tract infections (UTIs), within 30 days following the pelvic fractures. This retrospective cohort study examined claim records from the Longitudinal Health Insurance Database 2000 (LHID2000). We selected patients hospitalized with pelvic fractures between 1997 and 2013 for study. Patients who had index data before 2000 or after 2010 (n = 963), who died before the index date (n = 64), who were aged <18 years (n = 94), or who had a pelvic injury (n = 31) were excluded. In total, the study cohort comprised 1623 adult patients; 115 had UTIs, and 1508 patients without UTIs were used as a comparison cohort. Multivariate analysis with a multiple Cox regression model and Kaplan-Meier survival analysis were performed to analyze the data. Our results showed that the 1-year mortality rate (adjusted hazard ratio [HR]: 2.32; 95% CI: 1.25-4.29) and readmission rate (adjusted HR: 1.72; 95% CI: 1.26-3.34) of the UTI group were significantly higher than those of the non-UTI group. Moreover, the Kaplan-Meier curve for the 1-year follow-up indicated that the UTI group had a higher cumulative risk of both mortality and hospital readmission compared with the non-UTI group. In conclusion, among patients with pelvic fracture, patients with UTI were associated with increased risks of mortality and readmission. Physicians must pay more attention to such patients to prevent UTIs among patients with pelvic fractures during hospitalization and conduct a follow-up after discharge within at least 1 year.Entities:
Keywords: mortality; pelvic fracture; re-admissions; urinary tract infections
Year: 2021 PMID: 34063602 PMCID: PMC8124968 DOI: 10.3390/ijerph18094868
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart for patient selection.
Baseline characteristics among study groups.
| Variables | Non-UTI | UTI | |
|---|---|---|---|
| Sex | <0.0001 | ||
| Female | 823(54.58%) | 85(73.91%) | |
| Male | 685(45.42%) | 30(26.09%) | |
| Age | <0.0001 | ||
| 18–40 | 551(36.54%) | 31(26.96%) | |
| 41–65 | 566(37.53%) | 32(27.83%) | |
| >65 | 391(25.93%) | 52(45.22%) | |
| Comorbidities | |||
| Hypertension | 358(23.74%) | 52(45.22%) | <0.0001 |
| Diabetes mellitus | 216(14.32%) | 31(26.96%) | 0.0003 |
| Hyperlipidemia | 145(9.62%) | 23(20%) | 0.0004 |
| Coronary artery disease | 165(10.94%) | 17(14.78%) | 0.2083 |
| Cerebrovascular accident | 131(8.69%) | 23(20%) | <0.0001 |
| CKD | 114(7.56%) | 15(13.04%) | 0.0361 |
| COPD | 169(11.21%) | 16(13.91%) | 0.3787 |
| Chronic liver diseases | 183(12.14%) | 18(15.65%) | 0.2698 |
| Heart failure | 72(4.77%) | 14(12.17%) | 0.0006 |
| Depression | 223(14.79%) | 19(16.52%) | 0.6148 |
| Osteoporosis | 233(15.45%) | 25(21.74%) | 0.0755 |
| Asthma | 75(4.97%) | 9(7.83%) | 0.1832 |
| Osteoarthritis | 378(25.07%) | 37(32.17%) | 0.0922 |
| Surgery for pelvic fracture | 177(11.74%) | 11(9.57%) | 0.4829 |
Incidence rate for the mortality risk and re-admission.
| Variable | Incidence Density * (95% CI) | cRR * (95% CI) | aHR * (95% CI) | |||
|---|---|---|---|---|---|---|
| Non-UTI | UTI | |||||
| Mortality | ||||||
| from index date to | ||||||
| 1 m | 0.60(0.31–1.17) | 2.67(0.86–8.30) | 4.37(1.18–16.1) | 0.0268 | 2.48(0.63–9.66) | 0.1897 |
| 2 m | 0.54(0.33–0.88) | 2.25(0.93–5.41) | 4.12(1.51–11.2) | 0.0056 | 2.43(0.84–7.03) | 0.1000 |
| 3 m | 0.49(0.32–0.75) | 2.44(1.22–4.89) | 4.87(2.16–10.9) | 0.0001 | 2.50(1.05–5.95) | 0.0369 |
| 6 m | 0.38(0.27–0.53) | 1.72(0.95–3.12) | 4.39(2.22–8.67) | <0.0001 | 2.31(1.11–4.78) | 0.0241 |
| 9 m | 0.31(0.22–0.42) | 1.59(0.96–2.64) | 5.02(2.78–9.07) | <0.0001 | 2.71(1.44–5.11) | 0.0019 |
| 1 year | 0.28(0.21–0.37) | 1.19(0.71–1.98) | 4.14(2.32–7.38) | <0.0001 | 2.32(1.25–4.29) | 0.0070 |
| Readmission | ||||||
| from index date to | ||||||
| 1 m | 4.93(3.90–6.22) | 18.1(11.4–28.8) | 3.47(2.07–5.83) | <0.0001 | 2.95(1.71–5.10) | 0.0001 |
| 2 m | 4.52(3.80–5.38) | 14.5(9.95–21.1) | 3.04(2.00–4.60) | <0.0001 | 2.68(1.73–4.15) | <0.0001 |
| 3 m | 4.16(3.59–4.83) | 12.3(8.78–17.3) | 2.80(1.93–4.07) | <0.0001 | 2.53(1.71–3.73) | <0.0001 |
| 6 m | 3.44(3.05–3.87) | 8.17(6.00–11.1) | 2.25(1.61–3.14) | <0.0001 | 1.98(1.40–2.80) | <0.0001 |
| 9 m | 2.99(2.68–3.32) | 6.61(4.95–8.83) | 2.11(1.55–2.87) | <0.0001 | 1.83(1.33–2.51) | 0.0002 |
| 1 year | 2.61(2.37–2.89) | 5.47(4.13–7.24) | 1.98(1.47–2.67) | <0.0001 | 1.72(1.26–2.34) | 0.0005 |
* Incidence rate, per 100 person months; cRR *, crude relative risk; aHR *, adjusted hazard ratio: adjusted for all variables.
Figure 2Kaplan–Meier curves of the cumulative proportions of mortality (a) and re-admission (b) in UTI and non-UTI.
Multiple Cox regression to estimate the hazard ratio for the mortality risk and re-admission.
| Variable | Mortality | Re-Admission | ||
|---|---|---|---|---|
| aHR (95% CI) | aHR (95% CI) * | |||
| UTI | ||||
| No | Reference | Reference | ||
| Yes | 2.32(1.25–4.29) | 0.0070 | 1.72(1.26–2.34) | 0.0005 |
| Sex | ||||
| Female | Reference | Reference | ||
| Male | 1.19(0.68–2.09) | 0.5248 | 1.23(1.01–1.51) | 0.0382 |
| Age | ||||
| 18–40 | Reference | Reference | ||
| 41–65 | 1.34(0.38–4.70) | 0.6434 | 1.01(0.77–1.32) | 0.9209 |
| >65 | 6.55(2.03–21.0) | 0.0016 | 1.57(1.14–2.14) | 0.0047 |
| Comorbidities (ref: non) | ||||
| Hypertension | 1.16(0.63–2.15) | 0.6229 | 0.99(0.76–1.28) | 0.9528 |
| Diabetes mellitus | 1.05(0.58–1.91) | 0.851 | 1.51(1.17–1.94) | 0.0014 |
| Hyperlipidemia | 0.54(0.25–1.15) | 0.1142 | 0.79(0.58–1.06) | 0.1254 |
| Coronary artery disease | 0.55(0.29–1.02) | 0.0581 | 0.88(0.66–1.18) | 0.4048 |
| Cerebrovascular accident | 1.54(0.84–2.82) | 0.1554 | 1.35(1.02–1.78) | 0.0328 |
| CKD | 2.80(1.60–4.90) | 0.0003 | 1.59(1.19–2.12) | 0.0016 |
| COPD | 1.84(1.01–3.37) | 0.0454 | 1.47(1.12–1.93) | 0.0045 |
| Chronic liver diseases | 1.42(0.79–2.58) | 0.2384 | 1.46(1.13–1.87) | 0.0028 |
| Heart failure | 2.79(1.54–5.06) | 0.0007 | 1.35(0.96–1.91) | 0.0777 |
| Depression | 1.09(0.58–2.05) | 0.7717 | 1.20(0.94–1.53) | 0.1335 |
| Osteoporosis | 0.94(0.53–1.67) | 0.8429 | 1.49(1.17–1.90) | 0.0010 |
| Asthma | 1.51(0.76–3.00) | 0.2349 | 1.46(1.01–2.09) | 0.0411 |
| Osteoarthritis | 1.39(0.81–2.39) | 0.2306 | 1.28(1.03–1.58) | 0.0226 |
| Surgery | ||||
| No | Reference | Reference | ||
| Yes | 0.58(0.13–2.50) | 0.4691 | 1.82(1.38–2.40) | <0.0001 |
* aHR, Adjusted Hazard Ratio: Adjusted for all variables.